Santiago Moreno

Western Michigan University — United States

Immunology and Microbiology · Life Sciences

75h-index23.2kcitations916works2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(295), HIV/AIDS Research and Interventions(289), HIV/AIDS drug development and treatment(278), HIV-related health complications and treatments(158), Pneumocystis jirovecii pneumonia detection and treatment(108)

Publications876 total

Beyond COVID-19 in people with HIV: Specific miRNA expression profile persist after SARS-CoV-2 clearance
Journal of Infection and Public Health·2025Open Access
A Review of Doxycycline Post-Exposure Prophylaxis and Its Implications for Antimicrobial Resistance and the Human Microbiome
Infectious Diseases and Therapy·2025Open Access
Intensification with a CCR5 inhibitor at antiretroviral therapy initiation modulates interleukin-18 and inflammation-driven immune pathways in people with HIV
International Journal of Infectious Diseases·2025Open Access
Clarifying INSTINCT: Switching From DTG/3TC to BIC/FTC/TAF Shows Comparable Inflammatory and Weight Outcomes
Clinical Infectious Diseases·2025Open Access
Advancing integration in the approach to older adults with HIV: perspectives from geriatric and HIV specialists
BMC Geriatrics·2025Open Access
EE231 Cost-Effectiveness Model of Ranolazine for Treating Chronic Stable Angina Patients From Kingdom of Saudi Arabia Perspective
Value in Health·2025
Low-effort HIV training in Spanish primary care: Long-term impact on testing and diagnosis
Enfermedades infecciosas y microbiologia clinica (English ed )·2025
Trends in Age-Related Health Outcomes in People with HIV in Spain, 2006–2023
Clinical Infectious Diseases·2025
Cervical microbiota diversity and functional shifts in the development of cervical high-grade squamous intraepithelial lesions
Frontiers in Medicine·2025Open Access
Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study)
Clinical Infectious Diseases·2025· 4 citedOpen Access
Two or Three? Clinical and Proteomic Perspectives on Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV Treatment
Open Forum Infectious Diseases·2025Open Access
C0075 IMPACTO EN SALUD PÚBLICA ESTIMADO DE LA VACUNACIÓN FRENTE HERPES ZOSTER DE ADULTOS INMUNOCOMPROMETIDOS CON LA VACUNA RECOMBINANTE ADYUVADA EN ESPAÑA
Vacunas·2025
NOTE-FY Project: International stakeholder engagement on research in nocturnal oxygen therapy for pulmonary fibrosis
2025
Low-effort HIV training in Spanish primary care: Long-term impact on testing and diagnosis
Enfermedades Infecciosas y Microbiología Clínica·2025
Identification of Inflammation Markers as Novel Potential Predictors of the HIV-DNA Reservoir Size
International Journal of Molecular Sciences·2025Open Access
Enhancement of the fruity flavor in coffee beverages by solid-state fermentation in green coffee: a multi-block approach
Food Research International·2025
A Phase IV, Open-label, Single-Arm, Multicentric Clinical Trial for Evaluation of Human Papillomavirus 9vHPV Vaccine Immunogenicity in Men Who Have Sex With Men With HIV: GeSIDA Study 10 017
Clinical Infectious Diseases·2025· 1 citedOpen Access
Cost-Effective, Low Latency Vector Search with Azure Cosmos DB
Proceedings of the VLDB Endowment·2025
Long-Acting Cabotegravir and Rilpivirine in Patients With HIV With Solid Organ Transplantation: A Case Series
Open Forum Infectious Diseases·2025Open Access
HTLV-2 Enhances CD8+ T Cell-Mediated HIV-1 Inhibition and Reduces HIV-1 Integrated Proviral Load in People Living with HIV-1
UNC Libraries·2025Open Access
page 1 of 44Next →

Frequent Co-authors

Sergio Serrano‐Villar(11), Carmen Quereda(9), Fernando Dronda(8), Jesús Fortün(8), Pilar Martín‐Dávila(8), Talía Sainz(7), Maria Jesús Pérez‐Elías(7), José L. Casado(6), José A. Pérez‐Molina(6), Juan Berenguer(5), Emilio Bouza(5), Ana Moreno(5), Enrique Navas(5), Vicente Pintado(5), Julia del Amo(5), Jorge del Romero(4), Vicente Estrada(4), María Ángeles Muñoz‐Fernández(4), Rafael Bárcena(4), Rafael Rubio(4)